Abstract
We investigated a nested reverse transcriptase polymerase chain reaction (RT-PCR) system to detect CK20 mRNA in thyroid carcinomas, benign thyroid diseases and peripheral blood to improve diagnosis of thyroid carcinoma and to detect disseminated tumour cells. Frozen tissue samples of 46 thyroid carcinomas and 30 benign thyroid diseases (14 multinodular goiters, 14 follicular adenomas, two Hashimoto’s hyroiditis) were obtained intraoperatively. Preoperative blood samples were drawn from 31 patients with thyroid cancer, nine patients with benign thyroid disorders and 20 healthy volunteers. Nine out of nine medullary, 9/12 follicular, 7/19 papillary and 2/6 anaplastic carcinomas expressed CK20 transcripts. CK20 mRNA was undetectable in 30 tissue sections of benign thyroid diseases. Circulating tumour cells were found in the blood of 3/8 patients with medullary carcinoma, 2/8 patients with follicular carcinoma, 2/11 patients with papillary carcinoma and 1/4 patients with an anaplastic carcinoma. Nine blood samples of patients with benign thyroid diseases and 20 healthy volunteers tested negative. For the first time CK20 mRNA could be detected in tissue sections of thyroid carcinomas and peripheral blood samples of patients with thyroid cancer. It was not detectable in benign thyroid diseases. Our results therefore strongly suggest that CK20 RT-PCR assays may improve the diagnosis of thyroid carcinoma and is able to detect circulating tumour cells in peripheral blood of thyroid carcinoma patients. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B and Selby P (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase – polymerase chain reaction. Br J Cancer 71: 278–281
Gharib H (1994) Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations and effect. Mayo Clin Proc 69: 44–49
Ghossein RA and Rosai J (1996) Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78: 10–16
Gunn J, McCall JL, Yun K and Wright PA (1996) Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 75: 611–616
Johnson PWM, Burchill SA and Selby PJ (1995) The molecular detection of circulating tumor cells. Br J Cancer 72: 268–276
Klein A, Zemer R, Buchumensky V, Klaper R and Nissenkorn I (1998) Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. Cancer 82: 349–354
Moll R, Schiller DL and Franke WW (1990) Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 111: 567–580
Moll R, Löwe A, Laufer J and Franke WW (1992) Cytokeratin 20 in human carcinomas. Am J Pathol 140: 427–447
Moll R, Zimbelmann R, Goldschmidt MD, Keith M, Laufer J, Kasper M, Koch PJ and Franke WW (1993) The human gene encoding cytokeratin 20 and ist expression during fetal development and in gastrointestinal carcinomas. Differentiation 53: 75–93
Raue F (1995) Struma maligna. Nuklearmed 3: 147–152
Ringel MD, Ladenson PW and Levine MA (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83: 4435–4442
Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306
Schröder S, Wodzynski A and Padberg B (1996) Zytokeratinexpression benigner und maligner epithelialer Schilddrüsentumoren. Pathologe 17: 425–432
Smanik PA, Ryu KY, Theil KS, Mazzaferri EL and Jhiang SM (1997) Expression, exonintron organization, and chromosome mapping of the human sodium iodine symporter. Endocrinology 138: 3555–3558
Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B and Kalthoff H (1997) Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57: 3106–3110
Tallini G, Ghossein RA, Emanuel J, Gill J, Kinder B, Dimich AB, Costa J, Robbins R, Burrow GN and Rosai J (1998) Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 16: 1158–1166
Tezelman S and Clark OH (1995) Current management of thyroid cancer. Adv Surg 28: 191–221
Weber T, Hölting T, Klar E and Herfarth C (1997) The value of scintigraphy for diagnosis in differentiated thyroid cancer is questionable. Eur J Cancer 33: 272–273 (abstract)
Weber T, Ridder R, Willeke F, Lacroix J, Hölting T, Elser H, Klar E, Herfarth C and von Knebel Doeberitz M (1998) Detection of thyroglobulin mRNA in peripheral blood of patients with thyroid cancer. J Endocrinol Invest 21: 12 (abstract)
Weitz J, Kienle P, Lacroix J, Willeke F, Benner A, Lehnert T, Herfarth C and von Knebel Doeberitz M (1998) Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res 4: 343–348
Wyld DK, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J and Burchill SA (1998) Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79: 288–293
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Weber, T., Lacroix, J., Weitz, J. et al. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction. Br J Cancer 82, 157–160 (2000). https://doi.org/10.1054/bjoc.1999.0893
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.0893
Keywords
This article is cited by
-
Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
British Journal of Cancer (2005)